1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)

M.P. Ducreux, R. Desgrippes, Y. Rinaldi,F. Di Fiore, R. Guimbaud, L. Evesque,J-B. Bachet, P. Vanelslander, T. Lecomte, O. Capitain, A. Parzy, M. Bolliet,P.L. Etienne, J. Forestier,F. El Hajbi,A.L. Bignon Bretagne,V. Ly Lebrun,N. De Sousa Carvalho, M. Texier, O. Bouche

Annals of Oncology(2023)

引用 0|浏览4
暂无评分
关键词
advanced pancreatic carcinoma,chemotherapy,gemcitabine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要